共 13 条
[7]
Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial[J] . Yukito Shinohara,Yasuo Katayama,Shinichiro Uchiyama,Takenori Yamaguchi,Shunnosuke Handa,Kempei Matsuoka,Yasuo Ohashi,Norio Tanahashi,Hiroko Yamamoto,Chokoh Genka,Yasuhisa Kitagawa,Hideo Kusuoka,Katsuya Nishimaru,Motoo Tsushima,Yukihiro Koretsune,Tohru Sawada,Chikuma Hamada.Lancet Neurology . 2010 (10)
[8]
Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study[J] . Yining Huang,Yan Cheng,Jiang Wu,Yansheng Li,En Xu,Zhen Hong,Zhengyi Li,Weiwei Zhang,Meiping Ding,Xuguang Gao,Dongsheng Fan,Jinsheng Zeng,Kasing Wong,Chuanzhen Lu,Jiangxi Xiao,Chen Yao.Lancet Neurology . 2008 (6)
[9]
Stroke in China: epidemiology, prevention, and management strategies[J] . Ming Liu,Bo Wu,Wen-Zhi Wang,Li-Ming Lee,Shi-Hong Zhang,Ling-Zhi Kong.Lancet Neurology . 2007 (5)
[10]
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data[J] . Alan D Lopez,Colin D Mathers,Majid Ezzati,Dean T Jamison,Christopher JL Murray.The Lancet . 2006 (9524)